So, if we have the anticipated success that we may have, picks in the 16-30 range are going to wind up as valuable or more valuable than what Hall would be?
I understand that in a perfect world, the extension would have been agreed to well ahead of the deal. But that ups the price significantly, and was why qe put the conditional agreements in where if Hall re-signs or we win in the 1st round, we only owe a 2nd. If both happen, then it becomes a 1st.
If we were to have continued playing at a high level and maintained being in the top 2 of the Pacific and managed to win the 1st round series, I guarantee we are the front-runner for Hall.
The 1st that was lost for next year was lost because of the testing issues, and was in no way related to Hall re-signing or not. You are arguing the difference between a 2021 2nd and 1st for signing a player long term (or a 3rd to a 2nd, at the least). That is nothing for 5-7 years of an elite player.
It looks worse because people can't separate that the loss of our 1st round pick this year had nothing to do with Hall. Had that not happened, we would be looking at Merkley, Bahl, 2020 1st and 2021 3rd. Again, that is not much to give up, and if we see success that makes that 3rd turn into a 2nd or 1st - that success directly translates into re-signing Hall. A late 1st was given up for players like Paul Gaustad, as an example. The price appears worse because of the testing punishment.